Literature DB >> 24523470

Disseminated infection with Mycobacterium tilburgii in a male immunocompromised patient.

Sarah Temmerman1, Linos Vandekerckhove, Erica Sermijn, Dirk Vogelaers, Geert Claeys, Mario Vaneechoutte, Piet Cools, Steven Callens.   

Abstract

Mycobacterium tilburgii is a nonculturable nontuberculous mycobacterium identifiable only by molecular methods. We report a case of disseminated M. tilburgii infection illustrating the importance of 16S rRNA gene sequencing to determine the responsible mycobacterial pathogen and the difficulties in tailoring antimycobacterial treatment in the absence of a culturable organism.

Entities:  

Mesh：

Substances：

Year:  2014        PMID： 24523470      PMCID： PMC3993618          DOI： 10.1128/JCM.03148-13

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN： 0095-1137            Impact factor:   5.948


  17 in total

Review 1.  Newly described or emerging human species of nontuberculous mycobacteria.

Authors:  Barbara A Brown-Elliott; David E Griffith; Richard J Wallace
Journal:  Infect Dis Clin North Am       Date:  2002-03       Impact factor: 5.982

2.  Detection, identification, and treatment of a novel, non-cultivable Mycobacterium species in an HIV patient.

Authors:  E Richter; S Rüsch-Gerdes; S Niemann; A Stoehr; A Plettenberg
Journal:  AIDS       Date:  2000-07-28       Impact factor: 4.177

3.  A high proportion of novel mycobacteria species identified by 16S rDNA analysis among slowly growing AccuProbe-negative strains in a clinical setting.

Authors:  Ryan J Pauls; Christine Y Turenne; Joyce N Wolfe; Amin Kabani
Journal:  Am J Clin Pathol       Date:  2003-10       Impact factor: 2.493

4.  Identification of bacteria recovered from clinical specimens by 16S rRNA gene sequencing.

Authors:  P Kiratisin; L Li; P R Murray; S H Fischer
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2003-10-01       Impact factor: 3.267

Review 5.  Impact of 16S rRNA gene sequence analysis for identification of bacteria on clinical microbiology and infectious diseases.

Authors:  Jill E Clarridge
Journal:  Clin Microbiol Rev       Date:  2004-10       Impact factor: 26.132

6.  Fatal infection with a novel, unidentified mycobacterium in a man with the acquired immunodeficiency syndrome.

Authors:  B Hirschel; H R Chang; N Mach; P F Piguet; J Cox; J D Piguet; M T Silva; L Larsson; P R Klatser; J E Thole
Journal:  N Engl J Med       Date:  1990-07-12       Impact factor: 91.245

7.  Detection and identification of mycobacteria by amplification of rRNA.

Authors:  B Böddinghaus; T Rogall; T Flohr; H Blöcker; E C Böttger
Journal:  J Clin Microbiol       Date:  1990-08       Impact factor: 5.948

Review 8.  Mycobacterial diseases in primary immunodeficiencies.

Authors:  J Reichenbach; S Rosenzweig; R Döffinger; S Dupuis; S M Holland; J L Casanova
Journal:  Curr Opin Allergy Clin Immunol       Date:  2001-12

9.  Identification of Mycobacterium species by using amplified ribosomal DNA restriction analysis.

Authors:  M Vaneechoutte; H De Beenhouwer; G Claeys; G Verschraegen; A De Rouck; N Paepe; A Elaichouni; F Portaels
Journal:  J Clin Microbiol       Date:  1993-08       Impact factor: 5.948

10.  Evaluation of amplified rDNA restriction analysis (ARDRA) for the identification of cultured mycobacteria in a diagnostic laboratory.

Authors:  Thierry De Baere; Ricardo de Mendonça; Geert Claeys; Gerda Verschraegen; Wouter Mijs; Rita Verhelst; Sylvianne Rottiers; Leen Van Simaey; Catharine De Ganck; Mario Vaneechoutte
Journal:  BMC Microbiol       Date:  2002-03-01       Impact factor: 3.605
View more
  1 in total

1.  Functional Immune Reconstitution by Interleukin-2 Adjunctive Therapy for HIV/Mycobacterial Co-infection.

Authors:  Jan Heyckendorf; Sven Philip Aries; Ulf Greinert; Elvira Richter; Holger Schultz; Christoph Lange
Journal:  Emerg Infect Dis       Date:  2015-09       Impact factor: 6.883
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.